跳至主要内容
临床试验/NL-OMON30243
NL-OMON30243尚未招募不适用

Brain development after prenatal growth retardation; effects of growth hormone treatment - brain development after prenatal growth retardation; growth hormone

Vrije Universiteit Medisch Centrum0 个研究点目标入组 110 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 11(—)

入选标准

  • Indications for GH treatment is based on the protocol as described by the dutch Working group on Growth Hormone
  • inclusioncriteria for group A (SGA-short; without GH treatment):
  • - Birth weight or birth length below *2 SD adjusted for duration of pregnancy.
  • - Present height below *2.5 SD and below minus 1 SD target height-SDS.
  • - Calendar age between 4 and 6 years.
  • - No evidence of catch up growth during the preceding year.
  • - Children are under regular control by pediatrician, but do not choose to be treated with GH ;Inclusion criteria group B: (SGA-short; with GH treatment)
  • This is a patient population who meet the criteria for SGA-short, (see inclusion criteria group a) and are willing to be treated with GH. ;Inclusion criteria group C (SGA-normal height):
  • - Birth weight or birth length below *2 SD adjusted for duration of pregnancy.
  • - Present height above -2.0 SD and above minus 1 SD of target height -SDS.
  • - Calendar age between 4 and 6 years.;Inclusion criteria group D ( AGA-normal height):
  • - Normal birth weight/length adjusted for duration of pregnancy
  • - Present height above *2 SD for age and within target range (TH plus and minus 2 SD)
  • - Calendar age between 4 and 6 years.;inclusion criteria for group E (SGA-short; with GH treatment):
  • - Birth weight or birth length below *2 SD adjusted for duration of pregnancy.
  • - Present height below *2.5 SD and less than 1 SD below target height-SDS.
  • - Calendar age above 6 years.
  • - No evidence of catch up growth during the preceding year.
  • - Children are under regular control by pediatrician, are willing to be treated with GH

排除标准

  • Dysmorphic criteria or a known syndrome (except for Silver Russell syndrome)
  • Skeletal dysplasia
  • Serious complications in the neonatal period
  • Other diseases, responsible for growth failure
  • Medication influencing growth
  • Psychomotor retardation
  • Prematurity < 35 weeks

研究者

相似试验

已完成
不适用
Brain Development after prenatal growth retardation: effects of growth hormone treatmentSmall for Gestational Age (SGA), brain developmentNutritional, Metabolic, EndocrineBrain development
ISRCTN20279720Pfizer B.V. (The Netherlands)110
尚未招募
不适用
Brain development after prenatal growth retardation; effects of growth hormone treatment.Study populations:group A/B: small for gestational age (sga), children without complete catch up growth with and without growth hormone treatmentgroup C: sga with complete catch up growth group D:. Children born with a normal birth weight/length and a normal postnatal growth.
NL-OMON29167Prof Dr HA Delemarre- van de Waal110
招募中
不适用
The Structural Change of Fetal Brain Development among Diabetic Mother in Bhumibol Adulyadej HospitalFetal distress or fetal demise.Maternal complication such as pre-eclampsiafetal brain structures, diabetes pregnant woman, gestational diabetes
TCTR20240503001Bhumibol Adulyadej Hospital310
招募中
不适用
ormal fetal neurodevelopment; healthy control population as a comparison for fetuses with a congenital heart diseaseCongenital heart diseaseIntra-uterine neurodevelopmental disorders
NL-OMON26893eiden University Medical Center70
尚未招募
不适用
A study to document the long-term benefits of Kangaroo Mother Care (skin to skin contact and exclusive breast feeding) initiated at home during neonatal period on brain development at 6-7 years of child age.
CTRI/2021/09/036103Centre for Health Research and Development Society for Applied Studies